Purple Biotech Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$19,880,000 over the previous period. Total operating expenses were -$22,467,000.

Profit Margin

Purple Biotech Ltd. (NASDAQ:PPBT): Profit margin
2014 0 -5.25M
2015 0 -4.20M
2016 0 -12.12M
2017 901K -12.27M -1362.04%
2018 1M -5.2M -520%
2019 1M -6.10M -610.9%
2020 1M -12.40M -1240.5%
2021 -320K -18.46M 5769.69%
2022 -910K -20.82M 2288.46%
2023 0 -19.88M

PPBT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
0-910K-320K1M1M1M901K000
Cost of revenue
196K201K231K235K8003.99K09990
Gross profit
-196K-1.11M-551K765K999.92K1M897K0-9990
Operating exp.
Research and development
17.03M16.32M11.82M7.48M2.67M5.26M4.64M4.18M2.56M3.19M
Selling and marketing
0321K286K235K000000
Total operating expenses
-22.46M22.60M17.93M13.79M8.75M8.82M12.06M7.18M4.06M5.18M
Operating income
22.27M-22.60M-17.93M12.61M-7.15M-7.82M-12.24M-7.18M-4.06M-5.18M
Other income (expenses), net
-42.24M843K108K-15.46M1.26M2.74M-947K-5.07M-133K-71K
Income before tax
-19.97M-21.76M-17.82M-28.07M-5.89M-5.56M-13.00M-12.12M-4.20M-5.25M
Income tax expense
0-935K637K-15.66M216K-2.62M26K4.94M133K50K
Net income
-19.88M-20.82M-18.46M-12.40M-6.10M-5.2M-12.27M-12.12M-4.20M-5.25M
Earnings per share
Basic EPS
-0.08-1.13-1.04-0.72-3.15-0.27-0.63-21.07-0.22-234.38
Diluted EPS
-0.08-1.13-1.04-0.72-3.15-0.27-0.63-21.07-0.22-234.38
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source